478
Views
44
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Swedish guidelines for diagnosis and treatment of infective endocarditis

, , , , , , , , , , , & show all
Pages 929-946 | Received 20 Mar 2007, Published online: 08 Jul 2009

References

  • Hogevik, H. Endocarditis: epidemiology and clinical presentation. Thesis Göteborg University, GöteborgSweden 1996.
  • Snygg-Martin, U. Gender differences in endocarditis in a nationwide Swedish study. 8th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections, Charleston, USA, 2005.
  • Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96: 200–9
  • Alestig K, Hogevik H, Olaison L. Infective endocarditis: a diagnostic and therapeutic challenge for the new millennium. Scand J Infect Dis 2000; 32: 343–56
  • Thalme A, Westling K, Julander I. In hospital and longterm mortality in infective endocarditis in injecting drug users compared to non-drug users: A retrospective study of 192 episodes. Scand J Infect Dis 2007; 39: 197–204
  • Ilstrup DM, Washington JA 2nd. The importance of volume of blood cultured in the detection of bacteraemia and fungaemia. Diagn Microbiol Infect Dis 1983; 1: 107–10
  • Cockerill FR 3rd, Wilson JW, Vetter EA, Goodman KM, Torgerson CA, Harmsen WS. Optimal testing parameters for blood cultures. Clin Infect Dis 2004; 38: 1724–30
  • Baron EJ, Scott JD, Tompkins LS. Prolonged incubation and extensive subculturing do not increase recovery of clinically significant microorganisms from standard automated blood cultures. Clin Infect Dis 2005; 41: 1677–80
  • Morris AJ, Drinkovic D, Pottumarthy S, MacCulloch D, Kerr AR, West T. Bacteriological outcome after valve surgery for active infective endocarditis: implications for duration of treatment after surgery. Clin Infect Dis 2005; 41: 187–94
  • Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiological aspects of infective endocarditis in an urban population. A 5-y prospective study. Medicine (Baltimore) 1995; 74: 324–39
  • Werner M, Andersson R, Olaison L, Hogevik H. A clinical study of culture-negative endocarditis. Medicine (Baltimore) 2003; 82: 263–73
  • Morris AJ, Drinkovic D, Pottumarthy S, Strickett MG, MacCulloch D, Lambie D, et al. Gram stain, culture, and histopathological examination findings for heart valves removed because of infective endocarditis. Clin Infect Dis 2003; 36: 697–704
  • Millar BC, Moore JE. Current trends in the molecular diagnosis of infective endocarditis. Eur J Clin Microbiol Infect Dis 2004; 23: 353–65
  • Benn M, Hagelskjaer LH, Tvede M. Infective endocarditis, 1984 through 1993: a clinical and microbiological survey. J Intern Med 1997; 242: 15–22
  • Kurland S, Enghoff E, Landelius J, Nystrom SO, Hambraeus A, Friman G. A 10-y retrospective study of infective endocarditis at a university hospital with special regard to the timing of surgical evaluation in S. viridans endocarditis. Scand J Infect Dis 1999; 31: 87–91
  • Pazin GJ, Saul S, Thompson ME. Blood culture positivity: suppression by outpatient antibiotic therapy in patients with bacterial endocarditis. Arch Intern Med 1982; 142: 263–8
  • Werner AS, Cobbs CG, Kaye D, Hook EW. Studies on the bacteraemia of bacterial endocarditis. JAMA 1967; 202: 199–203
  • Werner M, Fournier PE, Andersson R, Hogevik H, Raoult D. Bartonella and Coxiella antibodies in 334 prospectively studied episodes of infective endocarditis in Sweden. Scand J Infect Dis 2003; 35: 724–7
  • Ehrenborg C. Bartonella Infections in Sweden: Clinical Investigations and Molecular Epidemiology. Uppsala University. 2007
  • Hogevik H, Olaison L, Andersson R, Alestig K. C-reactive protein is more sensitive than erythrocyte sedimentation rate for diagnosis of infective endocarditis. Infection 1997; 25: 82–5
  • Olaison L, Hogevik H, Alestig K. Fever, C-reactive protein, and other acute-phase reactants during treatment of infective endocarditis. Arch Intern Med 1997; 157: 885–92
  • Verhagen, D. Prognostic value of serial C-reactive protein measurement in patients with left-sided native valve endocarditis (Abstract). 8th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections. Charleston, 2005.
  • Chirillo, F, Pedrocco, A, De Leo, A, Bruni, A, Totis, O, Meneghetti, P, , et al. Impact of harmonic imaging on transthoracic echocardiographic identification of infective endocarditis and its complications. Heart 2005:329–33.
  • Reynolds HR, Jagen MA, Tunick PA, Kronzon I. Sensitivity of transthoracic versus transoesophageal echocardiography for the detection of native valve vegetations in the modern era. J Am Soc Echocardiogr 2003; 16: 67–70
  • Humpl T, McCrindle BW, Smallhorn JF. The relative roles of transthoracic compared with transoesophageal echocardiography in children with suspected infective endocarditis. J Am Coll Cardiol 2003; 41: 2068–71
  • Heidenreich PA, Masoudi FA, Maini B, Chou TM, Foster E, Schiller NB, et al. Echocardiography in patients with suspected endocarditis: a cost-effectiveness analysis. Am J Med 1999; 107: 198–208
  • Daniel WG, Mugge A, Grote J, Hausmann D, Nikutta P, Laas J, et al. Comparison of transthoracic and transoesophageal echocardiography for detection of abnormalities of prosthetic and bioprosthetic valves in the mitral and aortic positions. Am J Cardiol 1993; 71: 210–5
  • Daniel WG, Mugge A, Martin RP, Lindert O., Hausmann D, Nonnast-Daniel B, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transoesophageal echocardiography. N Engl J Med 1991; 324: 795–800
  • Fowler VG, Jr, Li J, Corey GR, Boley J, Marr KA, Gopal AK, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteraemia: experience in 103 patients. J Am Coll Cardiol 1997; 30: 1072–8
  • Sullenberger AL, Avedissian LS, Kent SM. Importance of transoesophageal echocardiography in the evaluation of Staphylococcus aureus bacteraemia. J Heart Valve Dis 2005; 14: 23–8
  • Jacob S, Tong AT. Role of echocardiography in the diagnosis and management of infective endocarditis. Curr Opin Cardiol 2002; 17: 478–85
  • Fantin B, Carbon C. In vivo antibiotic synergism: contribution of animal models. Antimicrob Agents Chemother 1992; 36: 907–12
  • Francioli PB, Glauser MP. Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis. Antimicrob Agents Chemother 1993; 37: 207–12
  • Falagas ME, Manta KG, Ntziora F, Vardakas KZ. Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. J Antimicrob Chemother 2006; 58: 273–80
  • Fowler VG, Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, et al. Daptomycin versus standard therapy for bacteraemia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355: 653–65
  • Le T, Bayer AS. Combination antibiotic therapy for infective endocarditis. Clin Infect Dis 2003; 36: 615–21
  • Graham JC, Gould FK. Role of aminoglycosides in the treatment of bacterial endocarditis. J Antimicrob Chemother 2002; 49: 437–44
  • Westling K, Julander I, Ljungman P, Jalal S, Nord CE, Wretlind B. Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes. Int J Antimicrob Agents 2006; 28: 292–6
  • Francioli P, Ruch W, Stamboulian D. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 d: a prospective multicentre study. Clin Infect Dis 1995; 21: 1406–10
  • Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye E, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 1995; 274: 1706–13
  • Sexton DJ, Tenenbaum MJ, Wilson WR, Steckelberg JM, Tice AD, Gilbert D, et al. Ceftriaxone once daily for 4 weeks compared with ceftriaxone plus gentamicin once daily for 2 weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis 1998; 27: 1470–4
  • Stein DS, Nelson KE. Endocarditis due to nutritionally deficient streptococci: therapeutic dilemma. Rev Infect Dis 1987; 9: 908–16
  • Elliott TS, Foweraker J, Gould FK, Perry JD, Sandoe JA. Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2004; 54: 971–81
  • Baddour LM. Infective endocarditis caused by beta-haemolytic streptococci. The Infectious Diseases Society of America's Emerging Infections Network. Clin Infect Dis 1998; 26: 66–71
  • Fantin B, Carbon C. Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis. Antimicrob Agents Chemother 1990; 34: 2387–91
  • Olaison L, Schadewitz K. Enterococcal endocarditis in Sweden, 1995–1999: can shorter therapy with aminoglycosides be used?. Clin Infect Dis 2002; 34: 159–66
  • Gavalda J, Len O, Miro JM, Munjoz P, Monteio M, Alarcon A, et al. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med 2007; 146: 574–9
  • Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in non-addicts: A prospective study. Ann Intern Med 1982; 97: 496–503
  • Ribera E, Gomez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez-Alujas T, et al. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ann Intern Med 1996; 125: 969–74
  • Torres-Tortosa M, de Cueto M, Vergara A, Sanchez-Porto A, Perez-Guzman E, Gonzalez-Serrano M, et al. Prospective evaluation of a 2-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cadiz. Eur J Clin Microbiol Infect Dis 1994; 13: 559–64
  • Fortun J, Navas E, Martinez-Beltran J, Perez-Molina J, Martin-Davila P, Guerrero A, et al. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. Clin Infect Dis 2001; 33: 120–5
  • Dodek P, Phillips P. Questionable history of immediate-type hypersensitivity to penicillin in staphylococcal endocarditis: treatment based on skin-test results versus empirical alternative treatment: a decision analysis. Clin Infect Dis 1999; 29: 1251–6
  • Karchmer A. Infective endocarditis. Harrison. Principles of Internal Medicine 2004; 6: 109
  • Kugler KC, Biedenbach DJ, Jones RN. Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms. Diagn Microbiol Infect Dis 1999; 34: 73–6
  • Tunkel, AR. Evaluation of culture-negative endocarditis. Hosp Pract (Off Ed) 1993;28:59–62, 65–6.
  • Karchmer AW, Archer GL, Dismukes WE. Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis. Rev Infect Dis 1983; 5(Suppl 3)S543–8
  • Karchmer AW, Longworth DL. Infections of intracardiac devices. Cardiol Clin 2003; 21: 253–71
  • Westling K, Thalme A, Julander I. Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole. Scand J Infect Dis 2005; 37: 310–1
  • Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965–1995. Clin Infect Dis 2001; 32: 50–62
  • Pierrotti LC, Baddour LM. Fungal endocarditis, 1995–2000. Chest 2002; 122: 302–10
  • Nguyen MH, Nguyen ML, Yu VL, McMahon D, Keys TF, Amidi M. Candida prosthetic valve endocarditis: prospective study of 6 cases and review of the literature. Clin Infect Dis 1996; 22: 262–7
  • Hogevik H, Alestig K. Fungal endocarditis: a report on 7 cases and a brief review. Infection 1996; 24: 17–21
  • Jimenez-Exposito MJ, Torres G, Baraldes A, Benito N, Marco F, Pare JC, et al. Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment. Clin Infect Dis 2004; 39: 70–3
  • Rajendram R, Alp NJ, Mitchell AR, Bowler IC, Forfar JC. Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement. Clin Infect Dis 2005; 40: 72–4
  • Rundstrom H, Kennergren C, Andersson R, Alestig K, Hogevik H. Pacemaker endocarditis during 18 y in Goteborg. Scand J Infect Dis 2004; 36: 674–9
  • Loffler S, Kasper J, Postulka J, Cornak V, Bohunicky F, Zelenay J, et al. Septic complications in patients with permanent pacemakers. Cor Vasa 1988; 30: 400–4
  • Bohm A, Banyai F, Preda I, Zamolyi K. The treatment of septicaemia in pacemaker patients. Pacing Clin Electrophysiol 1996; 19: 1105–11
  • Arber N, Pras E, Copperman Y, Schapiro JM, Meiner V, Lossos IS, et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine (Baltimore) 1994; 73: 299–305
  • Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997; 95: 2098–107
  • Cacoub P, Leprince P, Nataf P, Hausfater P, Dorent R, Wechsler B, et al. Pacemaker infective endocarditis. Am J Cardiol 1998; 82: 480–4
  • Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001; 345: 1318–30
  • Mansur AJ, Dal Bo CM, Fukushima JT, Issa VS, Grinberg M, Pomerantzeff PM. Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after infective endocarditis. Am Heart J 2001; 141: 78–86
  • Stamboulian D, Bonvehi P, Arevalo C, Bologna R, Cassetti I, Scilingo V, et al. Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. Rev Infect Dis 1991; 13(Suppl 2)S160–3
  • Francioli P, Etienne J, Hoigne R, Thys JP, Gerber A. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA 1992; 267: 264–7
  • Rehm SJ. Outpatient intravenous antibiotic therapy for endocarditis. Infect Dis Clin North Am 1998; 12: 879–901
  • Monteiro CA, Cobbs CG. Outpatient management of infective endocarditis. Curr Infect Dis Rep 2001; 3: 319–27
  • Stamboulian D. Outpatient treatment of endocarditis in a clinic-based programme in Argentina. Eur J Clin Microbiol Infect Dis 1995; 14: 648–54
  • Andrews MM, Von Reyn CF. Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis. Clin Infect Dis 2001; 33: 203–9
  • Chan KL, Dumesnil JG, Cujec B, Santillippo AJ, Jue J, Turek MA. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003; 42: 775–80
  • John MD, Hibberd PL, Karchmer AW, Sleeper LA, Calderwood SB. Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis 1998; 26: 1302–9
  • Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J. Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med 1999; 159: 473–5
  • Olaison L, Pettersson G. Current best practices and guidelines. Indications for surgical intervention in infective endocarditis. Cardiol Clin 2003; 21: 235–51
  • Alexiou C, Langley SM, Stafford H, Lowes JA, Livesey SA, Monro JL. Surgery for active culture-positive endocarditis: determinants of early and late outcome. Ann Thorac Surg 2000; 69: 1448–54
  • Soma Y, Handa S, Iwanaga S. Medical treatment or surgical intervention? A cooperative retrospective study on infective endocarditis: timing of operation. Jpn Circ J 1991; 55: 799–803
  • Baddour LM, Wilson WR, Bayer AS, Fowler VG, Jr, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications–a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anaesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: 394–434
  • Olaison L, Hogevik H, Myken P, Oden A, Alestig K. Early surgery in infective endocarditis. QJM 1996; 89: 267–78
  • Anguera I, Miro JM, Cabell CH, Abrutyn E, Fowler VG, Jr, Hoen B, et al. Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the International Collaboration on Endocarditis Merged Database. Am J Cardiol 2005; 96: 976–81
  • Bauernschmitt R, Jakob HG, Vahl CF, Lange R, Hagl S. Operation for infective endocarditis: results after implantation of mechanical valves. Ann Thorac Surg 1998; 65: 359–64
  • Steckelberg JM, Murphy JG, Ballard D, Bailey K, Tajik AJ, Taliercio CP, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991; 114: 635–40
  • Truninger K, Attenhofer Jost CH, Seifert B, Vogt PR, Follath F, Schaffner A, et al. Long -term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone?. Heart 1999; 82: 714–20
  • De Castro S, Magni G, Beni S, Cartoni D, Fiorelli M, Venditti M, et al. Role of transthoracic and transoesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am J Cardiol 1997; 80: 1030–4
  • Di Salvo G, Habib G, Pergola V, Avierinos JF, Philip E, Vailloud JM, et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001; 37: 1069–76
  • Heiro M, Nikoskelainen J, Engblom E, Kotilainen E, Marttila R, Kotilainen P. Neurologic manifestations of infective endocarditis: a 17-y experience in a teaching hospital in Finland. Arch Intern Med 2000; 160: 2781–7
  • Olaison, L. Infective endocarditis. Studies on diagnostic criteria and effects of treatment. Dissertation. Göteborg University, Sweden, 1997.
  • Olaison L, Belin L, Hogevik H, Alestig K. Incidence of beta-lactam-induced delayed hypersensitivity and neutropenia during treatment of infective endocarditis. Arch Intern Med 1999; 159: 607–15
  • Yu VL, Fang GD, Keys TF, Harris AA, Gentry LO, Fuchs PC, et al. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg 1994; 58: 1073–7
  • Lytle, BW, Priest, BP, Taylor, PC, Loop, FD, Sapp, SK, Stewart, RW, , et al. Surgical treatment of prosthetic valve endocarditis. J Thorac Cardiovasc Surg 1996;111:198–207; discussion 207–10.
  • Pansini S, di Summa M, Patane F, Forsennati PG, Serra M, Del Ponte S. Risk of recurrence after reoperation for prosthetic valve endocarditis. J Heart Valve Dis 1997; 6: 84–7
  • Raoult, D, Marrie, T. Q fever. Clin Infect Dis 1995;20:489–95; quiz, 496.
  • Gillinov, AM, Shah, RV, Curtis, WE, Stuart, RS, Cameron, DE, Baumgartner, WA, , et al. Valve replacement in patients with endocarditis and acute neurological deficit. Ann Thorac Surg 1996;61:1125–9, discussion 1130.
  • Horstkotte D, Weist K, Ruden H. Better understanding of the pathogenesis of prosthetic valve endocarditis: recent perspectives for prevention strategies. J Heart Valve Dis 1998; 7: 313–5
  • Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. Multicentre retrospective study in Japan. J Thorac Cardiovasc Surg 1995; 110: 1745–55
  • Ting, W, Silverman, N, Levitsky, S. Valve replacement in patients with endocarditis and cerebral septic emboli. Ann Thorac Surg 1991;51:18–21, discussion 22.
  • Matsushita K, Kuriyama Y, Sawada T, Yamaguchi T, Nagata S, Kawazoe K, et al. Haemorrhagic and ischaemic cerebrovascular complications of active infective endocarditis of native valve. Eur Neurol 1993; 33: 267–74
  • Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Hofer D, Poewe W, et al. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 2006; 37: 2094–9
  • Guerra JM, Tornos MP, Permanyer-Miralda G, Almirante B, Murtra M, Soler-Soler J. Long-term results of mechanical prostheses for treatment of active infective endocarditis. Heart 2001; 86: 63–8
  • Aagaard, J, Andersen, PV. Acute endocarditis treated with radical debridement and implantation of mechanical or stented bioprosthetic devices. Ann Thorac Surg 2001;71:100–3, discussion 104.
  • Baumgartner FJ, Omari BO, Robertson JM, Nelson RJ, Pandya A, Milliken JC. Annular abscesses in surgical endocarditis: anatomic, clinical, and operative features. Ann Thorac Surg 2000; 70: 442–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.